Home > Our news > Partner Jennifer O’Farrell provides commentary on Actavis UK Ltd and others v Eli Lilly and Company decision


6 October, 2017

Biotechnology and Life Sciences practice group Partner Jennifer O’Farrell has recently provided commentary on landmark decision by the UK Supreme court on Actavis UK Ltd and others v Eli Lilly and Company [2017] UKSC 48 for the Thomson Reuters Practical Law’s Life Sciences section. The article provides practical advice and an indication of the wider implications of the decision, which the Boult Wade Tennant’s Biotechnology and Life Sciences group have been closely following.

Please click here to read the full article.